$MWBN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sunshine Biopharma, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sunshine Biopharma, Inc. Get notifications about new insider transactions in Sunshine Biopharma, Inc for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2021 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 20,000,000 | 20,000 | 23,342,500 | 3.3 M to 23.3 M (+598.35 %) |
| Feb 16 2021 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 20,000,000 | 20,000 | 23,343,461 | 3.3 M to 23.3 M (+598.18 %) |
| Feb 16 2021 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO/Secretary | Grant | A | 0.00 | 20,000,000 | 20,000 | 23,893,086 | 3.9 M to 23.9 M (+513.73 %) |
| Jul 15 2020 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO/Secretary | Grant | A | 0.00 | 323,673 | 324 | 0 | 323.7 K to 0 (-100.00 %) |
| Jul 15 2020 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO/Secretary | Grant | A | 0.00 | 1,300,000 | 1,300 | 3,893,086 | 2.6 M to 3.9 M (+50.13 %) |
| Jul 15 2020 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO/Secretary | Grant | A | 0.00 | 1,100,000 | 1,100 | 2,593,086 | 1.5 M to 2.6 M (+73.67 %) |
| Jul 15 2020 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO/Secretary | Grant | A | 0.00 | 550,000 | 550 | 1,493,086 | 943.1 K to 1.5 M (+58.32 %) |
| Jul 13 2020 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 1,300,000 | 1,300 | 3,342,500 | 2 M to 3.3 M (+63.65 %) |
| Jul 13 2020 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 1,100,000 | 1,100 | 2,042,500 | 942.5 K to 2 M (+116.71 %) |
| Jul 10 2020 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Buy | J | 0.00 | 323,673 | 324 | 861,209 | 537.5 K to 861.2 K (+60.21 %) |
| Jul 10 2020 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 1,300,000 | 1,300 | 3,343,461 | 2 M to 3.3 M (+63.62 %) |
| Jul 10 2020 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 1,100,000 | 1,100 | 2,043,461 | 943.5 K to 2 M (+116.59 %) |
| Jun 25 2020 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.10 | 500,000 | 50,000 | 1,000,000 | 500 K to 1000 K (+100.00 %) |
| Oct 07 2019 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 13,000,000 | 13,000 | 18,850,000 | 5.9 M to 18.9 M (+222.22 %) |
| Sep 23 2019 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | Secretary | Grant | A | 0.00 | 11,000,000 | 11,000 | 29,861,719 | 18.9 M to 29.9 M (+58.32 %) |
| Sep 23 2019 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | Secretary | Grant | A | 0.00 | 13,000,000 | 13,000 | 18,861,719 | 5.9 M to 18.9 M (+221.78 %) |
| Sep 23 2019 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 13,000,000 | 13,000 | 18,869,219 | 5.9 M to 18.9 M (+221.49 %) |
| Sep 14 2018 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 38,000,000 | 38,000 | 118,467,000 | 80.5 M to 118.5 M (+47.22 %) |
| Sep 14 2018 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | Secretary | Grant | A | 0.00 | 38,000,000 | 38,000 | 117,234,373 | 79.2 M to 117.2 M (+47.96 %) |
| Sep 14 2018 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 38,000,000 | 38,000 | 117,384,373 | 79.4 M to 117.4 M (+47.87 %) |
| Jun 28 2018 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 27,000,000 | 27,000 | 80,467,000 | 53.5 M to 80.5 M (+50.50 %) |
| Jun 28 2018 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | Secretary | Grant | A | 0.00 | 27,000,000 | 27,000 | 79,234,373 | 52.2 M to 79.2 M (+51.69 %) |
| Jun 28 2018 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 27,000,000 | 27,000 | 79,384,373 | 52.4 M to 79.4 M (+51.54 %) |
| Sep 08 2017 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 14,000,000 | 14,000 | 53,467,000 | 39.5 M to 53.5 M (+35.47 %) |
| Sep 08 2017 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | Secretary | Grant | A | 0.00 | 14,000,000 | 14,000 | 52,234,373 | 38.2 M to 52.2 M (+36.62 %) |
| Sep 08 2017 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 14,000,000 | 14,000 | 52,384,373 | 38.4 M to 52.4 M (+36.47 %) |
| Dec 15 2016 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.00 | 26,000,000 | 26,000 | 39,467,000 | 13.5 M to 39.5 M (+193.06 %) |
| Dec 15 2016 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO and Secretary | Grant | A | 0.00 | 26,000,000 | 26,000 | 38,234,373 | 12.2 M to 38.2 M (+212.52 %) |
| Dec 15 2016 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.00 | 26,000,000 | 26,000 | 38,384,373 | 12.4 M to 38.4 M (+209.94 %) |
| Nov 07 2016 | MWBN | Sunshine Biopharma ... | Advanomics Corp | 10% Owner | Sell | J | 0.00 | 136,861,968 | 0 | 215,014,224 | 351.9 M to 215 M (-38.89 %) |
| Nov 07 2016 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO and Secretary | Buy | J | 0.00 | 129,468,927 | 0 | 129,468,927 | 0 to 129.5 M |
| Nov 07 2016 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Sell | J | 0.00 | 136,861,968 | 0 | 215,014,224 | 351.9 M to 215 M (-38.89 %) |
| Aug 01 2016 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Buy | J | 0.00 | 321,305,416 | 835,394 | 351,876,192 | 30.6 M to 351.9 M (+1,051.02 %) |
| Apr 26 2016 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Grant | A | 0.01 | 12,000,000 | 84,000 | 12,384,373 | 384.4 K to 12.4 M (+3,121.97 %) |
| Apr 26 2016 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Buy | P | 0.20 | 253,082 | 50,009 | 30,570,776 | 30.3 M to 30.6 M (+0.83 %) |
| Apr 25 2016 | MWBN | Sunshine Biopharma ... | Sebaaly Camille | CFO and Secretary | Grant | A | 0.01 | 12,000,000 | 84,000 | 12,234,373 | 234.4 K to 12.2 M (+5,120.04 %) |
| Apr 25 2016 | MWBN | Sunshine Biopharma ... | MERZOUKI ABDERRAZZAK | Chief Operating Off ... | Grant | A | 0.01 | 12,000,000 | 84,000 | 13,467,000 | 1.5 M to 13.5 M (+818.00 %) |
| Jun 01 2015 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Buy | P | 0.10 | 500,000 | 50,000 | 500,000 | 0 to 500 K |
| Jan 22 2015 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Buy | J | 0.02 | 150,000 | 3,000 | 384,373 | 234.4 K to 384.4 K (+64.00 %) |
| Jan 22 2015 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Sell | J | 0.02 | 1,200,000 | 24,000 | 30,317,694 | 31.5 M to 30.3 M (-3.81 %) |
| Sep 07 2012 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Option Exercise | C | 0.00 | 17,000,000 | 0 | 0 | |
| Sep 07 2012 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Sell | S | 0.05 | 2,591,500 | 129,575 | 31,517,694 | 34.1 M to 31.5 M (-7.60 %) |
| Sep 07 2012 | MWBN | Sunshine Biopharma ... | Slilaty Steve N. | Chief Executive Off ... | Buy | C | 0.00 | 17,000,000 | 0 | 34,109,194 | 17.1 M to 34.1 M (+99.36 %) |
Page: 1